Lemelin A, Takemura K, Boyne D, Warkentin M, Brenner D, Cheun W, Wells J, Labaki C, McGregor B, Basappa N, Meza L, Pal S, Beuselinck B, McKay R, Szabados B, Powles T, Yuasa T, Ludwig L, Choueiri T, Heng D. 1902P Comparison of cabozantinib (CABO) versus sunitinib (SUN) following first-line (1L) nivolumab plus ipilimumab (NIVO+IPI) for metastatic renal cell carcinoma (mRCC): A target trial emulation using real-world data from the International mRCC Database Consortium (IMDC). Annals Of Oncology 2023, 34: s1023-s1024. DOI: 10.1016/j.annonc.2023.09.1132.Peer-Reviewed Original Research